Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Staphylococcal and streptococcal infections are common infectious diseases and can range from mild, superficial skin infections to severe, life-threatening systemic infections. Staphylococcus aureus, group A streptococcus, and Streptococcus pneumoniae are the three major pathogens. The prevalence of invasive infections caused by community-associated meticillin-resistant S. aureus and group A streptococci appears to be increasing. The emergence of drug resistance (e.g. meticillin and glycopeptide resistance in S. aureus, macrolide resistance in group A streptococci and penicillin resistance in S. pneumoniae), is causing concern and could threaten successful treatment. Streptococcus suis has emerged as an important human pathogen. © 2014 Published by Elsevier Ltd.

Original publication

DOI

10.1016/j.mpmed.2013.10.016

Type

Journal

Medicine (United Kingdom)

Publication Date

01/01/2014

Volume

42

Pages

1 - 7